NASDAQ:ZGNX - Zogenix News Headlines

Sign in or create an account to add this stock to your watchlist.
$49.35 +0.20 (+0.41 %)
(As of 09/24/2018 04:00 PM ET)
Previous Close$49.15
Today's Range$48.75 - $49.50
52-Week Range$11.80 - $62.75
Volume263,218 shs
Average Volume639,192 shs
Market Capitalization$1.76 billion
P/E Ratio-12.29
Dividend YieldN/A
Beta2.14

Headlines

Zogenix (NASDAQ ZGNX) News Headlines

Source:
DateHeadline
 Analysts Anticipate Zogenix, Inc. (ZGNX) to Post -$0.92 EPS Analysts Anticipate Zogenix, Inc. (ZGNX) to Post -$0.92 EPS
www.americanbankingnews.com - September 22 at 8:08 PM
Zogenix, Inc. (ZGNX) Receives Consensus Rating of "Buy" from AnalystsZogenix, Inc. (ZGNX) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - September 17 at 11:23 AM
Zogenix Has $3.4B Opportunity With Pediatric Epilepsy Asset, BofA Says In Bullish InitiationZogenix Has $3.4B Opportunity With Pediatric Epilepsy Asset, BofA Says In Bullish Initiation
finance.yahoo.com - September 14 at 4:41 PM
Bank of America Begins Coverage on Zogenix (ZGNX)Bank of America Begins Coverage on Zogenix (ZGNX)
www.americanbankingnews.com - September 14 at 12:33 PM
Northland Capital Markets Starts Zogenix, Inc. (ZGNX) at OutperformNorthland Capital Markets Starts Zogenix, Inc. (ZGNX) at Outperform
www.streetinsider.com - September 13 at 8:55 AM
Northland Securities Begins Coverage on Zogenix (ZGNX)Northland Securities Begins Coverage on Zogenix (ZGNX)
www.americanbankingnews.com - September 12 at 1:14 PM
Heres Why Zogenix Slipped 14.9% in AugustHere's Why Zogenix Slipped 14.9% in August
www.fool.com - September 10 at 3:13 PM
Zogenix (ZGNX) Coverage Initiated by Analysts at B. RileyZogenix (ZGNX) Coverage Initiated by Analysts at B. Riley
www.americanbankingnews.com - September 8 at 6:55 PM
Dont Dread a Market Correction, Think Opportunistically InsteadDon't Dread a Market Correction, Think Opportunistically Instead
finance.yahoo.com - September 8 at 4:46 PM
Benzingas Top Upgrades, Downgrades For September 7, 2018Benzinga's Top Upgrades, Downgrades For September 7, 2018
www.benzinga.com - September 7 at 4:49 PM
Insider Selling: Zogenix, Inc. (ZGNX) EVP Sells 7,000 Shares of StockInsider Selling: Zogenix, Inc. (ZGNX) EVP Sells 7,000 Shares of Stock
www.americanbankingnews.com - September 5 at 7:34 PM
 Brokerages Anticipate Zogenix, Inc. (ZGNX) Will Post Earnings of -$0.91 Per Share Brokerages Anticipate Zogenix, Inc. (ZGNX) Will Post Earnings of -$0.91 Per Share
www.americanbankingnews.com - September 5 at 6:16 PM
Zogenixs ZX008 shows positive effect in mid-stage study in rare childhood epilepsy; shares up 5% premarketZogenix's ZX008 shows positive effect in mid-stage study in rare childhood epilepsy; shares up 5% premarket
seekingalpha.com - September 4 at 4:51 PM
Global Phase 3 Randomized, Controlled Study in LGS Currently Enrolling PatientsGlobal Phase 3 Randomized, Controlled Study in LGS Currently Enrolling Patients
globenewswire.com - September 4 at 8:57 AM
Zogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut SyndromeZogenix Phase 2 Study Results Published in Epilepsia Show ZX008 Provides Durable Reduction in Seizure Frequency in Patients With Lennox-Gastaut Syndrome
finance.yahoo.com - September 4 at 8:57 AM
Todays Research Reports on Trending Tickers: CRISPR Therapeutics and ZogenixToday's Research Reports on Trending Tickers: CRISPR Therapeutics and Zogenix
finance.yahoo.com - September 4 at 8:57 AM
Zogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on EpileptologyZogenix Announces New Data on Psychological and Socioeconomic Impact of Dravet Syndrome and Other Epileptic Encephalopathies at 13th European Congress on Epileptology
finance.yahoo.com - August 30 at 8:57 AM
Zogenix Becomes Oversold (ZGNX)Zogenix Becomes Oversold (ZGNX)
www.nasdaq.com - August 29 at 9:00 AM
Edited Transcript of ZGNX earnings conference call or presentation 6-Aug-18 8:30pm GMTEdited Transcript of ZGNX earnings conference call or presentation 6-Aug-18 8:30pm GMT
finance.yahoo.com - August 16 at 4:59 PM
Zogenix Inc. (ZGNX) CEO Stephen Farr on Q2 2018 Results - Earnings Call TranscriptZogenix Inc. (ZGNX) CEO Stephen Farr on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 7 at 8:57 AM
Zogenix: 2Q Earnings SnapshotZogenix: 2Q Earnings Snapshot
finance.yahoo.com - August 7 at 8:57 AM
Zogenix Provides Corporate Update and Reports Second Quarter Financial ResultsZogenix Provides Corporate Update and Reports Second Quarter Financial Results
finance.yahoo.com - August 6 at 5:05 PM
Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6Zogenix to Release Second Quarter 2018 Financial Results and Host Conference Call and Webcast on August 6
finance.yahoo.com - August 1 at 9:46 AM
Tilray’s IPO is creating a buzz, but don’t overspend on marijuana stocksTilray’s IPO is creating a buzz, but don’t overspend on marijuana stocks
finance.yahoo.com - July 27 at 8:53 AM
3 Very Popular Marijuana Stocks on My "Do Not Buy" List3 Very Popular Marijuana Stocks on My "Do Not Buy" List
finance.yahoo.com - July 20 at 8:38 AM
Zogenix (ZGNX) in Focus: Stock Moves 9.8% HigherZogenix (ZGNX) in Focus: Stock Moves 9.8% Higher
www.zacks.com - July 16 at 8:25 AM
Todays Research Reports on Trending Tickers: Zogenix and Momenta PharmaceuticalsToday's Research Reports on Trending Tickers: Zogenix and Momenta Pharmaceuticals
finance.yahoo.com - July 16 at 8:25 AM
Zogenix, Inc. (ZGNX) PT Raised to $65 at Stifel Following Phase 3 ZX008 ResultsZogenix, Inc. (ZGNX) PT Raised to $65 at Stifel Following Phase 3 ZX008 Results
www.streetinsider.com - July 14 at 4:11 PM
Why Zogenix Inc. Shares Jumped 10% on FridayWhy Zogenix Inc. Shares Jumped 10% on Friday
finance.yahoo.com - July 14 at 4:11 PM
Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome StudyZogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study
www.benzinga.com - July 14 at 4:11 PM
Zogenixs Epilepsy Candidate Successful in Phase III StudyZogenix's Epilepsy Candidate Successful in Phase III Study
finance.yahoo.com - July 14 at 4:11 PM
Why Twitter, Papa Johns International, and Zogenix Jumped TodayWhy Twitter, Papa John's International, and Zogenix Jumped Today
www.fool.com - July 13 at 4:11 AM
Zogenix Inc. (ZGNX) Has Broken Out To A New High On Study ResultsZogenix Inc. (ZGNX) Has Broken Out To A New High On Study Results
www.nasdaq.com - July 12 at 4:33 PM
Zogenix (ZGNX) Reports Positive Top-Line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet SyndromeZogenix (ZGNX) Reports Positive Top-Line Results from Second Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
www.streetinsider.com - July 12 at 4:33 PM
Zogenix Stock Soars on Positive Clinical Trial ResultsZogenix Stock Soars on Positive Clinical Trial Results
finance.yahoo.com - July 12 at 4:33 PM
Mid-Afternoon Market Update: Dow Up Over 200 Points; Zogenix Shares Gain On Positive Phase 3 Data In Dravet Syndrome StudyMid-Afternoon Market Update: Dow Up Over 200 Points; Zogenix Shares Gain On Positive Phase 3 Data In Dravet Syndrome Study
feeds.benzinga.com - July 12 at 3:31 PM
Why Zogenix Inc. Is Soaring TodayWhy Zogenix Inc. Is Soaring Today
www.fool.com - July 12 at 3:13 PM
Zogenix (ZGNX) Stock Soars on Anti-Seizure Drug ResultsZogenix (ZGNX) Stock Soars on Anti-Seizure Drug Results
investorplace.com - July 12 at 1:21 PM
Zogenixs ZX008 successful in second late-stage study in DravetZogenix's ZX008 successful in second late-stage study in Dravet
seekingalpha.com - July 12 at 8:37 AM
ZGNX Hits All-time High On Positive Dravet Syndrome Drug ResultsZGNX Hits All-time High On Positive Dravet Syndrome Drug Results
www.nasdaq.com - July 12 at 8:37 AM
Zogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatmentZogenix shares soar 19% premarket after news of positive trial for severe epilepsy treatment
www.marketwatch.com - July 12 at 8:37 AM
Benzingas Daily Biotech Pulse: Acceleron On Fast Lane, OncoCytes Accurate Diagnosis, Inspire Medical Gets Aetna ...Benzinga's Daily Biotech Pulse: Acceleron On Fast Lane, OncoCyte's Accurate Diagnosis, Inspire Medical Gets Aetna ...
www.benzinga.com - July 10 at 8:43 AM
New global chief commercial officer for ZogenixNew global chief commercial officer for Zogenix
seekingalpha.com - July 2 at 4:30 PM
Zogenix Welcomes New Global Chief Commercial OfficerZogenix Welcomes New Global Chief Commercial Officer
finance.yahoo.com - July 2 at 8:52 AM
The Week Ahead In Biotech: Delayed Clinical Trial Releases In FocusThe Week Ahead In Biotech: Delayed Clinical Trial Releases In Focus
feeds.benzinga.com - June 30 at 7:27 PM
US approves first marijuana plant-derived drug for epilepsyUS approves first marijuana plant-derived drug for epilepsy
www.reuters.com - June 25 at 5:07 PM
Commit To Purchase Zogenix At $30, Earn 19.7% Using OptionsCommit To Purchase Zogenix At $30, Earn 19.7% Using Options
www.nasdaq.com - June 15 at 5:03 PM
This Cannabis-Based Drug Is On the Verge of Making HistoryThis Cannabis-Based Drug Is On the Verge of Making History
finance.yahoo.com - May 28 at 8:57 AM
Reader Inquiry: Is There Further Upside In Zogenix?Reader Inquiry: Is There Further Upside In Zogenix?
seekingalpha.com - May 26 at 4:43 PM
Zogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare ConferenceZogenix to Participate in the Bank of America Merrill Lynch 2018 Healthcare Conference
globenewswire.com - May 14 at 9:10 AM
This page was last updated on 9/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel